Compare Stocks → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:IMV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIMVIMV$0.66$0.48▼$12.70$9.63M0.95233,607 shs44,800 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIMVIMV0.00%0.00%0.00%0.00%0.00%Do This Today BEFORE Biden Wins in November (Ad)Discover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIMVIMVN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIMVIMVN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIMVIMV$330K0.00N/AN/A($0.69) per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIMVIMV-$37.99M-$4.59N/AN/AN/A-11,547.42%-12,695.41%-104.84%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIMVIMVN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIMVIMVN/A2.932.93OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIMVIMV15.37%Insider OwnershipCompanyInsider OwnershipIMVIMV0.33%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableIMVIMV9711.71 million11.67 millionOptionableBVXP and IMV HeadlinesSourceHeadlineBioVaxys Technology Corp. Closes SECOND Tranche of Private Placementca.finance.yahoo.com - May 10 at 6:01 PMInflaRx N.V.: InflaRx Reports First Quarter 2024 Financial Results and Provides Business Updatefinanznachrichten.de - May 8 at 9:41 AMThe Kremlin scores propaganda points with a display of captured tanks and armour ahead of the Victory Day parademsn.com - May 8 at 12:22 AMBioVaxys Technology Corp. Closes First Tranche of Private Placementfinance.yahoo.com - May 3 at 8:14 PMVehicle documents scam : Mumbai Police arrest 3 RTO officers of Amravatithehitavada.com - May 3 at 4:01 AMFuture Market Insights Positioned for Growth as Veterinary Imaging Market Surges to achieve a valuation of US$ 3.37 Billion by 2030fmiblog.com - May 3 at 12:30 AMO.J. Simpson's lawyer ready to meet with Goldman, Brown familiesmsn.com - May 2 at 9:28 AMCancer: Monthly horoscope Maymsn.com - May 2 at 2:28 AMThe $10,000 Toyota Pickup You May Never Seetopspeed.com - May 1 at 9:12 AMBioVaxys Technology Corp.: Biovaxys Appoints Christopher Cherry As Chief Financial Officerfinanznachrichten.de - April 30 at 11:36 AMChery developing M-series 7-seater MPV/SUV and pick-up truck models, plus new Tiggo 3 and 5 by 2026paultan.org - April 30 at 8:09 AMPhilippines growth slows sharply in Marchjust-auto.com - April 23 at 9:42 AMWhy it’s likely Toyota will revive the ‘Stallion’ badge in SAcars.co.za - April 18 at 1:41 AMGWC introduces vision picking technology in Qatarzawya.com - April 16 at 8:13 AMHolliday's first hit helps the Orioles rally to a 6-4 win over the Brewers and avoid a sweepwsbtv.com - April 14 at 6:46 PMGolden Bachelor news: Gerry and Theresa break up, but still love each othermsn.com - April 13 at 9:37 AMThe future Toyota EVs that could trump Teslajust-auto.com - April 9 at 7:56 PMThe Pros And Cons Of Owning Toyota's $13,000 Pickup Truckmsn.com - April 7 at 10:44 AMBangkok 2024: Toyota Hilux Champ – workhorse truck; SWB and LWB; petrol/diesel; 5MT/6AT; from RM59kpaultan.org - April 5 at 7:24 AMToyota's Wacky Front and Rear Sliding Door Crossover Van Comes to Life Digitallyautoevolution.com - April 4 at 7:13 AMWhy are there so many cars in Omaha without license plates?msn.com - April 3 at 7:17 PMToyota's stout, crazy-modular $12K tiny truck makes enticing mini-RVnewatlas.com - April 3 at 7:17 PMVirginia Tech hires Marquette's Megan Duffy as new coachmsn.com - April 3 at 2:17 PMCalciMedica, Inc.: CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updatesfinanznachrichten.de - March 28 at 11:06 AMCompany DescriptionsIMVNASDAQ:IMVIMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
